Suzanne Lucot, MD
Child & Adolescent Psychiatry · Cranberry Township, PANPI 1629110606
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $60,390 of the $72,452 with a category attached, or 83.4%. Supernus Pharmaceuticals, Inc. accounts for 91.2% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $22,755, 5.0 times the $4,530 reported in 2019. Among child & adolescent psychiatry clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $267.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$66K
- Ironshore Pharmaceuticals Inc.$4K
- Alkermes, Inc.$432
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$401
- Otsuka America Pharmaceutical, Inc.$360
- Corium, LLC$263
- plus $803 from 13 others
What the payments were for
- Consulting fees$1,5202%
- Speaking & faculty fees$60,39083%
- Travel & lodging$4,7557%
- Food & beverage$5,7878%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$60,552
- Jornay PM 20mg capsules (Bottle of 100)$3,810
- LYBALVI$871
- ARISTADA$520
- CAPLYTA$352
- ARISTADA INITIO$130
- REXULTI$123
- SPRAVATO$105
- Azstarys$103
How this compares
$72,452 in reported general payments places this provider in the 95th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.
See all child & adolescent psychiatry providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 34 | $48,601 |
| TrintellixVortioxetine Hydrobromide | 30 | $13,694 |
| VyvanseLisdexamfetamine Dimesylate | 12 | $4,490 |
| Bupropion XlBupropion Hcl | 153 | $4,313 |
| Vilazodone Hcl | 44 | $4,072 |
| Fluvoxamine Maleate | 30 | $3,350 |
| Duloxetine Hcl | 102 | $2,191 |
| Aripiprazole | 53 | $1,489 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 66 | $1,452 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 50 | $1,401 |
| Trazodone Hcl | 117 | $1,399 |
| Divalproex Sodium ErDivalproex Sodium | 19 | $1,289 |
| Gabapentin | 33 | $1,287 |
| Methylphenidate ErMethylphenidate Hcl | 14 | $1,144 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 46 | $1,065 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $121 | $18,18442 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.
Other child & adolescent psychiatry in Cranberry Township
- Dennis BorczonErie$120K
- Dan UdreaWexford$51K
- Robert WilsonErie$34K
- Craig FeasterState College$18K
- Thomas WindPhiladelphia$17K
- Laura AdangPhiladelphia$15K
- Christoph LamPhiladelphia$13K
- Raman BawejaHershey$11K
- Jeffrey HermannYork$10K
- Mukundam VeerabathiniState College$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.